Laparoscopic cholecystectomy plus exploration of the common bile duct in comparison with laparoscopic cholecystectomy and endoscopic sphincterotomy for secondary choledocholithiasis
2012-08-15ZhangChunju
/Zhang Chunju
(张春菊,Dept Gener Surg,Shengjing Hosp,China Med Univ,Shenyang 110004)…∥Chin J Gen Surg.-2011,17(11).-736~738
ObjectiveTo compare the effects between laparoscopic cholecystectomy(LC)+laparoscopic common bile duct exploration(LCBDE)and endoscopic sphincterotomy(EST)+laparoscopic cholecystectomy(LC)for secondary choledocholithiasis.MethodsThe clinical data of patients with secondary choledocholithiasis receiving LC+LCBDE or EST+LC from January 2008 to December 2009 were retrospectively compared.Parameters included operation time,postoperative complication,length of stay,cost of hospitalization.All patients received follow up of 1 year.Enumeration data was analyzed by chisquare test and measurement data was analyzed by t test.ResultsIn this study 87 patients received LC+LCBDE,76 patients received EST+LC.Patients in LC + LCBDE group had shorter hospital stay,less hospital charges and less complications.There was not difference in the procedure success rate and stone remanent rate between the two groups.ConclusionLC+LCBDE could be used as the first choice for patients with gallstones and secondary choledocholithiasis.12 refs,2 tabs.
杂志排行
外科研究与新技术的其它文章
- Value of diffusion-weighted MR imaging and dynamic-contrast enhanced MRI in the diagnosis of breast cancer
- Meta-analysis of the efficacy between gemcitabine-alone and gemcitabine-based chemotherapy applied to advanced pancreatic cancer
- Effect of decompression in different time on hemodynamics and oxygen metabolism of porcine model with severe acute pancreatitis combined intraabdominal hypertension
- Postoperative use of Sorafenib in liver transplantation patients of hepatocellular carcinoma beyond Milan criteria
- Combined liver-kidney transplantation and orthotopic liver transplantation in the treatment of severe hepatitis B
- HO-1 up-regulation decreases liver ischemia/reperfusion injury by inhibiting mast cells degranulation